Metraipolis › archive › dc_4a9ff23fce70

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40121182
DOI
10.1093/ndt/gfaf060
License (as archived)
solo-consultazione
Archived
2026-11-10T05:03:45.948Z
SHA-256 of the archived text
1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351
Stable URL of this page
https://metraipolis.com/documento/dc_4a9ff23fce70

How to cite

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182 — Europe PMC (en), https://europepmc.org/article/MED/40121182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a9ff23fce70 (Metraipolis archive dc_4a9ff23fce70, sha256 1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351)
BibTeX
@misc{dc4a9ff23fce70,
  title = {Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40121182},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a9ff23fce70; sha256 1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40121182. Agents can read the archived copy with the MCP tool read_document.